Laboratory evaluation of ß-hydroxybutyrate levels in capillary and venous blood

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN31042751

Enrollment

Registered

2019-12-20

Start date

2020-01-06

Completion date

Unknown

Last updated

2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic ketoacidosis or ketosis Nutritional, Metabolic, Endocrine Diabetes mellitus with ketosis

Interventions

Participants will have venous and capillary blood collected, which may be repeated: - A maximum of 4 times - Or, until ketone levels return to normal - Or, participants are discharged from hospital

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 16 years or over 2. Potentially ketotic, or in diabetic ketoacidosis

Exclusion criteria

Exclusion criteria: 1. Already participated in this study 2. Concomitant medical condition which in the investigator’s opinion could interfere with the study or present a risk to the safety or welfare of the participant or study staff 3. Infected with hepatitis B virus (Hep B), hepatitis C virus (Hep C), or human immunodeficiency virus (HIV)

Design outcomes

Primary

Measure	Time frame
Capillary blood ß-hydroxybutyrate levels and venous blood ß-hydroxybutyrate levels as measured on the Randox Ranbut laboratory reference method using Bland-Altman analysis at each visit	—

Countries

England, Scotland, United Kingdom

Contacts

Public ContactPamela Reid

Pamela.Reid@abbott.com+44 (0)1993 863024

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026